FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/08/045063 [Registered on: 30/08/2022] Trial Registered Prospectively
Last Modified On: 29/08/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Behavioral 
Study Design  Single Arm Study 
Public Title of Study   STUDY TO SEE THE EFFECT OF SARASWATA CHURNA AND ASHWAGANDHASIDHKSHIR SHIRODHARA IN THE MANAGEMENT OF ATTENTION - DEFICIT HYPERACTIVITY DISORDER (ADHD) IN CHILDREN  
Scientific Title of Study   CLINICAL STUDY TO EVALUATE THE EFFECT OF SARASWATA CHURNA AND ASHWAGANDHASIDHKSHIR SHIRODHARA IN THE MANAGEMENT OF ATTENTION - DEFICIT HYPERACTIVITY DISORDER (ADHD) IN CHILDREN-SINGLE ARM OPEN LABELLED TRIAL  
Trial Acronym  Iattention, Hyperactivity, Shirodhara 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr MANVITA GIDWANI 
Designation  MD Scholar 
Affiliation  University Post Graduate Institute of Ayurved Studies Research 
Address  PG Department of Kaumarbhritya University Post Graduate Institute of Ayurved Studies Research DSRRAU Jodhpur Nagaur Road Kadwad Jodhpur Rajasthan

Jodhpur
RAJASTHAN
342037
India 
Phone  8740981455  
Fax    
Email  manvitagidwani10@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Harish Kumar Singhal 
Designation  Assistant Professor 
Affiliation  University Post Graduate Institute of Ayurved Studies Research 
Address  PG Department of Kaumarbhritya University Post Graduate Institute of Ayurved Studies Research DSRRAU Jodhpur Nagaur Road Kadwad Jodhpur Rajasthan

Jodhpur
RAJASTHAN
342037
India 
Phone  9636622206  
Fax    
Email  drharish_md@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Harish Kumar Singhal 
Designation  Assistant Professor 
Affiliation  University Post Graduate Institute of Ayurved Studies Research 
Address  PG Department of Kaumarbhritya University Post Graduate Institute of Ayurved Studies Research DSRRAU Jodhpur Nagaur Road Kadwad Jodhpur Rajasthan

Jodhpur
RAJASTHAN
342037
India 
Phone  9636622206  
Fax    
Email  drharish_md@yahoo.co.in  
 
Source of Monetary or Material Support  
University Post Graduate Institute of Ayurved Studies Research DSRRAU Jodhpur 
 
Primary Sponsor  
Name  University Post Graduate Institute of Ayurved Studies Research DSRRAU Jodhpur  
Address  PG Department of Kaumarbhritya University Post Graduate Institute of Ayurved Studies Research DSRRAU Jodhpur Nagaur Road Kadwad Jodhpur Rajasthan 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR MANVITA GIDWANI  University Post Graduate Institute of Ayurved Studies Research DSRRAU Jodhpur   PG Department of Kaumarbhritya University Post Graduate Institute of Ayurved Studies Research DSRRAU Jodhpur Nagaur Road Kadwad Jodhpur Rajasthan
Jodhpur
RAJASTHAN 
8740981455

manvitagidwani10@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committe  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:F900||Attention-deficit hyperactivity disorder, predominantly inattentive type. Ayurveda Condition: ADHD (MANOVAHA SROTAS VYADHI),  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical
2Intervention ArmDrugClassical(1) Medicine Name: Saraswata churna, Reference: Bhaishjya Ratnawali and Bhavprakash Samhita , Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: -madhu and ghrita), Additional Information: -
 
Inclusion Criteria  
Age From  6.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  1.Individual between age group of 6 to 12 years of both sexes having fulfill DSM V criteria. 
 
ExclusionCriteria 
Details  1.Individual below 6 year & above 12 years of age.
2.Mental disorders like conduct disorder, anxiety, depressive disorders, obsessive disorders & compulsive disorder.
3.Children with schizophrenia.
4.Children having medical illness like hearing loss, hypothyroidism, genetic disorder & seizures disorder.
5.Children having congenital deformity or Muscular dystrophy
 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
TO EVALUATE THE CLINICAL EFFICACY OF SARASWATA CHURNA AND ASHWAGANDHASIDHKSHIR SHIRODHARA IN THE MANAGEMENT OF ADHD   45 days 
 
Secondary Outcome  
Outcome  TimePoints 
To improve school performance and health status of children  45 days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/09/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="60"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NO 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The effect of saraswata churna and ashwagandhasidhkshir shirodhara in the management of ADHD in children. single arm open labelled trial.my aim is to relief the symptoms of adhd and my sample size is 60 children. duration of study 45 days. age group of 6 to 12 years of both sexes.my follow up every fortnightly and last follow up after 15 days of completion of study.saraswata churna will be in a dose in two divided doses as per young formula. while ashwagandhasidhkshir shirodhara will be given foe 15 days for a duration of 20 minutes daily.  
Close